1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow IMO-2055: new trials by email Literature Review of IMO-2055 trials Research Report on IMO-2055
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| REMUNE + AMPLIVAX IR103 HIV/AIDS Phase III Safety & Efficacy Study IR103 - HIV | Phase 3 | Unknown | Immune Response BioPharma, Inc. | 500 | 2017-06-01 | 2016-02-23 |
Immune Response BioPharma, Inc. (1)
United States (1)